文献速递冠心病心律失常血脂与心血管预防

全基因组跨种族荟萃分析发现调控凝血因子VIII与血管性血友病因子血浆水平的新关联

Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.
PubMed 文献 · Circulation · 2019-01-01

识别出13个新的全基因组显著关联(7个与FVIII水平相关,11个与VWF水平相关),并对多数位点进行功能验证;孟德尔随机化提示FVIII活性对静脉血栓和冠心病风险、VWF水平对缺血性卒中风险存在因果效应。

要点

  • 跨种族荟萃分析发现13个调控FVIII和VWF血浆水平的新基因位点。
  • 孟德尔随机化提示FVIII活性对静脉血栓和冠心病风险有因果效应。
  • VWF血浆水平对缺血性卒中风险存在因果效应。

核心结论

  • 荟萃分析识别出13个调控FVIII和VWF血浆水平的新基因位点,其中10个经功能验证。
  • 孟德尔随机化提供证据支持这些蛋白在血栓事件中的因果作用。

研究设计与样本

  • 对候选基因在培养内皮细胞中进行体外基因沉默以提供关联和功能的额外证据。
  • 应用两样本孟德尔随机化分析检验FVIII和VWF血浆水平对动脉和静脉血栓事件风险的因果作用。

主要发现

  • 识别出13个新的全基因组显著关联(P≤2.5×10-8),其中7个与FVIII水平相关(FCHO2/TMEM171/TNPO1、HLA、SOX17/RP1、LINC00583/NFIB、RAB5C-KAT2A、RPL3/TAB1/SYNGR1和ARSA)。
  • 11个与VWF水平相关(PDHB/PXK/KCTD6、SLC39A8、FCHO2/TMEM171/TNPO1、HLA、GIMAP7/GIMAP4、OR13C5/NIPSNAP、DAB2IP、C2CD4B、RAB5C-KAT2A、TAB1/SYNGR1和ARSA),超出此前报道的10个关联。
  • 功能验证为除ARSA和DAB2IP外所有VWF位点的关联提供了进一步证据。
  • 孟德尔随机化提示FVIII活性水平对静脉血栓和冠心病风险有因果效应,VWF水平对缺血性卒中风险有因果效应。

临床怎么用

  • 识别出的新基因位点可能有助于理解FVIII和VWF水平的遗传调控机制。
  • 孟德尔随机化证据支持FVIII和VWF作为血栓性疾病潜在治疗靶点的进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Factor VIII (FVIII) and its carrier protein von Willebrand factor (VWF) are associated with risk of arterial and venous thrombosis and with hemorrhagic disorders. We aimed to identify and functionally test novel genetic associations regulating plasma FVIII and VWF. METHODS: We meta-analyzed genome-wide association results from 46 354 individuals of European, African, East Asian, and Hispanic ancestry. All studies performed linear regression analysis using an additive genetic model and associated ≈35 million imputed variants with natural log-transformed phenotype levels. In vitro gene silencing in cultured endothelial cells was performed for candidate genes to provide additional evidence on association and function. Two-sample Mendelian randomization analyses were applied to test the causal role of FVIII and VWF plasma levels on the risk of arterial and venous thrombotic events. RESULTS: We identified 13 novel genome-wide significant ( P≤2.5×10-8) associations, 7 with FVIII levels ( FCHO2/TMEM171/TNPO1, HLA, SOX17/RP1, LINC00583/NFIB, RAB5C-KAT2A, RPL3/TAB1/SYNGR1, and ARSA) and 11 with VWF levels ( PDHB/PXK/KCTD6, SLC39A8, FCHO2/TMEM171/TNPO1, HLA, GIMAP7/GIMAP4, OR13C5/NIPSNAP, DAB2IP, C2CD4B, RAB5C-KAT2A, TAB1/SYNGR1, and ARSA), beyond 10 previously reported associations with these phenotypes. Functional validation provided further evidence of association for all loci on VWF except ARSA and DAB2IP. Mendelian randomization suggested causal effects of plasma FVIII activity levels on venous thrombosis and coronary artery disease risk and plasma VWF levels on ischemic stroke risk. CONCLUSIONS: The meta-analysis identified 13 novel genetic loci regulating FVIII and VWF plasma levels, 10 of which we validated functionally. We provide some evidence for a causal role of these proteins in thrombotic events.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Sabater-Lleal M, Huffman JE, de Vries PS, et al. Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels. Circulation. 2019. PMID: 30586737. doi:10.1161/CIRCULATIONAHA.118.034532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。